Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitis C

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 2, 2009, Pages 115-117

  Kabbaj, N ^a   Sentissi, S ^a   Mohammadi, M ^a   Benaissa A ^a   Amrani, N ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; AGED; ANTERIOR EYE CHAMBER; ANTIVIRAL THERAPY; ARTICLE; BLURRED VISION; CASE REPORT; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INTRAOCULAR HEMORRHAGE; ISCHEMIC OPTIC NEUROPATHY; MALE; OPHTHALMOSCOPY; PAPILLEDEMA; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL DISORDER;

AGED; ANTIVIRAL AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PAPILLEDEMA; RIBAVIRIN; VISUAL ACUITY;

EID: 60649118902     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.12.004     Document Type: Article

References (18)

1. Goncalves L.L., Farias A.Q., Gonçalves P.L., D'Amico E.A., and Carrilho F.J. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. World J Gastroenterol 12 (2006) 4602-4603
2. Sene D., Touitou V., Bodaghi B., Saadoun D., Perlemuter G., Cassoux N., et al. Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 13 (2007) 3137-3140
3. Zegans M.E., Anninger W., Chapman C., and Gordon S.R. Ocular manifestations of hepatitis C virus infection. Curr Opin Ophthalmol 13 (2002) 423-427
4. Abe T., Nakajima A., Satoh N., Koizumi T., Sakuragi S., Ono T., et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophtalmol 39 (1995) 411-419
5. Willson R.A. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol 38 (2004) 717-722
6. Vardizer Y., Linhart Y., Loewentein A., Garzozi H., Mazawi N., and Kesler A. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy. J Neuro Ophthalmol 23 (2003) 256-259
7. Sauer A., Lenoble P., Bader P., Speeg-Schatz C., Bourcier T., and Nasica X. Ocular complications of hepatitis C treatment. J Fr Ophtalmol 30 (2007) e20
8. Kirchhoff A., Kirchhoff U., Lafrenz M., and Guthoff R. Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha 2B and ribavirin. Klin Monatsbi Augenheilkd 221 (2004) 791-793
9. Chan J.W. Bilateral non-arteritic ischemic optic neuropathy associated with pegylated interferon for chronic hepatitis C. Eye 21 (2007) 877-878
10. Gupta R., Singh S., Tang R., Blackwell T.A., and Schiffman J.S. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 112 (2002) 683-684
11. Miserachs-García S., Mesa-Toledo E., Arruga-Ginebreda J., and Castillo-Campillo L. Ischemic neuroretinopathy associated with use of interferon. Arch Soc Esp Oftalmol 80 (2005) 533-535
12. Shahidullah A.B., Cerulli M.A., and Berman D.H. Interferon may cause retinopathy during hepatitis therapy. Am J Gastroenterol 90 (1995) 1543
13. Norcia F., Di Maria A., Prandini F., and Redaelli C. Natural interferon therapy: optic nerve ischemic damage?. Ophtalmologicagica 218 (1999) 339-340
14. Yaghi C., Baz P., Koussa S., Daniel F., Haddad F., and Sayegh R. Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin for acute hepatitis C. Gastroenterol Clin Biol 29 (2005) 616-617
15. Purvin V.A. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophtalmol 113 (1995) 1041-1044
16. Lohmann C.P., Kroher G., Bogenrieder T., Spiegel D., and Preuner J. Severe loss of vision during adjuvant interferon alfa 2b treatment for malignant melanoma. Lancet 353 (1999) 1326
17. Färkkilä M., Iivanainen M., Roine R., Bergström L., Laaksonen R., Niemi M.L., et al. Neurotoxic and other side effects of high dose interferon in ALS. Arch Neurol Scand 70 (1984) 42-46
18. Taylor J.L., and Grossberg S.E. The effects of interferon alpha on the production and action of other cytokines. Semin Oncol 25 (1998) 23-29